Abstract: The invention relates to a composition comprising at least two protective proteins against Streptococcus agalactiae (S. agalactiae) or functionally active variant thereof; a protective peptide against S. agalactiae; one or more nucleic acid(s) encoding the at least two proteins and/or the protective peptide; a method of producing the composition; a pharmaceutical composition, especially a vaccine, comprising the composition and/or at least one protective peptide; methods for producing antibodies; a mixture of antibodies against the at least two proteins of the composition; the use of the composition and/or at least one protective peptide and/or one or more nucleic acid(s) for the manufacture of a medicament for the immunization or treatment of a subject; methods of diagnosing a S.

Abstract: The present invention relates to a peptide consisting of one antigen of Streptococcus pyogenes (S. pyogenes) of any of the SEQ ID NOS: 1 to 7 or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition, especially a vaccine, comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing a S.

Abstract: The present invention relates to a protective peptide of Enterococcus faecalis (E. faecalis) or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing an E. faecalis infection; and the use of said peptide for the isolation and/or purification and/or identification of an interaction partner of the peptide.

Abstract: The present invention relates to a peptide consisting of one antigen of Streptococcus pyogenes (S. pyogenes) of any of the SEQ ID NOS: 1 to 7 or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition, especially a vaccine, comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing a S.

Abstract: The invention relates to a composition comprising at least two protective proteins against Streptococcus agalactiae (S. agalactiae) or functionally active variant thereof; a protective peptide against S. agalactiae; one or more nucleic acid(s) encoding the at least two proteins and/or the protective peptide; a method of producing the composition; a pharmaceutical composition, especially a vaccine, comprising the composition and/or at least one protective peptide; methods for producing antibodies; a mixture of antibodies against the at least two proteins of the composition; the use of the composition and/or at least one protective peptide and/or one or more nucleic acid(s) for the manufacture of a medicament for the immunization or treatment of a subject; methods of diagnosing a S.

Abstract: A decoating device for axially symmetric components, particularly from aircraft engines is provided, the decoating process being carried out through the use of a decoating fluid-which is brought on a localized basis into contact with the component to be decoated, a receptacle for holding the decoating fluid being provided that rotates at least about one axis of rotation, and the decoating fluid surface forming a rotation paraboloid in response to the rotation, the component(s) to be decoated on a localized basis being accommodated in the receptacle and being dipped on the radially outer side into the decoating fluid. A decoating device is thereby devised which makes it possible for radially symmetric components to be decoated in the radially outer region in a simple process.

Abstract: The present invention relates to a peptide consisting of one antigen of Streptococcus pyogenes (S. pyogenes) of any of the SEQ ID NOS: 1 to 7 or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition, especially a vaccine, comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing a S.

Abstract: The invention relates to a composition comprising at least two protective proteins against Streptococcus agalactiae (S. agalactiae) or functionally active variant thereof; a protective peptide against S. agalactiae; one or more nucleic acid(s) encoding the at least two proteins and/or the protective peptide; a method of producing the composition; a pharmaceutical composition, especially a vaccine, comprising the composition and/or at least one protective peptide; methods for producing antibodies; a mixture of antibodies against the at least two proteins of the composition; the use of the composition and/or at least one protective peptide and/or one or more nucleic acid(s) for the manufacture of a medicament for the immunization or treatment of a subject; methods of diagnosing a S.

Abstract: A loading device for transporting workpieces (3) from a readiness position, preferably a workpiece transport means, to a machining unit (1) and vice versa, or between machining units, is provided with a loading portal arranged above the machining site, on which linear robots (5, 6), bent-arm robots or similar means are arranged displaceably for transporting and releasing or picking up the workpieces (3) at or from the machining unit (1). One or more tray-like catching means (7) arranged under the workpieces (3) are also arranged displaceably at the loading portal (4, 10) with the displaceable means (5, 6).

Abstract: A loading device for transporting workpieces (3) from a readiness position, preferably a workpiece transport means, to a machining unit (1) and vice versa, or between machining units, is provided with a loading portal arranged above the machining site, on which linear robots (5, 6), bent-arm robots or similar means are arranged displaceably for transporting and releasing or picking up the workpieces (3) at or from the machining unit (1). One or more tray-like catching means (7) arranged under the workpieces (3) are also arranged displaceably at the loading portal (4, 10) with the displaceable means (5, 6).

Abstract: Lipid of blackcurrant seed is employed for treating of lipoprotein disorders associated with cholesterol metabolism. Its administration to humans produces an increase of cholesterol of the high-density lipoproteins and a reduction of the cholesterol of the low-density lipoproteins.

Abstract: Machine elements formed which overcome the problems associated with rolling bearings or rolling drive units, which, apart from load under rolling are simultaneously exposed to frictional load, which leads in particular zones to frictional wear. In order to keep this to a minimum the invention teaches to apply on the effected surfaces of such structural parts a coating of a friction bearing material, which, however, according to the findings of the invention must be applied with the PVD method and must have a thickness of the order of magnitude of the surface roughness of the base body; known thicker friction bearing coatings are not suitable. The invention is especially for forming gear wheels, rolling bearings, shafts, compressor screws, and rolling pistons.